Skip to main content
Addgene

pAcrVIB1-cloDF-amp
(Plasmid #184843)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 184843 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pUC19
  • Backbone size w/o insert (bp) 2742
  • Total vector size (bp) 3090
  • Modifications to backbone
    origin was exchanged with cloDF, lac cassette exchanged with constitutive promoter
  • Vector type
    Bacterial Expression, Synthetic Biology

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    anti-CRISPR protein inhibiting Cas13b nucleases
  • Alt name
    AcrVIB1
  • Species
    Riemerella anatipestifer
  • Insert Size (bp)
    347
  • GenBank ID
    WP_004917816.1
  • Promoter J23119

Cloning Information

  • Cloning method Gibson Cloning
  • 5′ sequencing primer TATCACGAGGCCCTTTCGTC
  • 3′ sequencing primer TGTGTGAGCTATGAGAAAGCGC
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pAcrVIB1-cloDF-amp was a gift from Chase Beisel (Addgene plasmid # 184843 ; http://n2t.net/addgene:184843 ; RRID:Addgene_184843)
  • For your References section:

    Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases. Wandera KG, Alkhnbashi OS, Bassett HVI, Mitrofanov A, Hauns S, Migur A, Backofen R, Beisel CL. Mol Cell. 2022 May 24. pii: S1097-2765(22)00437-3. doi: 10.1016/j.molcel.2022.05.003. 10.1016/j.molcel.2022.05.003 PubMed 35649413